Sudden Death Trajectories in HFpEF, HFmrEF
Clinical changes before death overlap across outcomes
-
By
-
Kathryn Wighton
-
March 31, 2026
-
Clinical Scorecard: Sudden Death Trajectories in HFpEF, HFmrEF
At a Glance
| Category | Detail |
|---|
| Condition | Heart Failure with Preserved Ejection Fraction (HFpEF) and Mildly Reduced Ejection Fraction (HFmrEF) |
| Key Mechanisms | Worsening functional status, symptom burden, and natriuretic peptide levels precede sudden death. |
| Target Population | Patients with symptomatic heart failure and left ventricular ejection fraction of 40% or greater. |
| Care Setting | Cardiology clinics and hospitals. |
Key Highlights
- Sudden death accounts for 25% to 30% of deaths in HFpEF.
- Modest worsening in NYHA class and KCCQ-TSS observed before sudden death.
- NT-proBNP levels increased significantly in patients who experienced sudden death.
- Current guidelines do not recommend implantable cardioverter-defibrillators for primary prevention.
- Nonspecific nature of changes limits immediate clinical actionability.
Guideline-Based Recommendations
Diagnosis
- Monitor NYHA functional class, KCCQ-TSS, and NT-proBNP levels.
Management
- No specific preventive strategies for sudden death recommended due to risk stratification limitations.
Monitoring & Follow-up
- Regular assessment of functional status and natriuretic peptide levels.
Risks
- Increased risk of sudden death associated with worsening functional class and declining health status.
Patient & Prescribing Data
Patients with symptomatic heart failure and ejection fraction ≥ 40%.
Focus on overall health status and functional improvement rather than specific sudden death prevention.
Clinical Best Practices
- Assess functional status and symptom burden regularly.
- Consider overall risk rather than specific sudden death risk for treatment decisions.
- Utilize patient-reported outcomes in monitoring.
References
